71 results on '"Marquet, Pierre"'
Search Results
2. Task-specific temporal prediction mechanisms revealed by motor and electroencephalographic indicators
3. Gut microbiota biotransformation of drug glucuronides leading to gastrointestinal toxicity: Therapeutic potential of bacterial β-glucuronidase inhibition in mycophenolate-induced enteropathy
4. Identification of non-adherence to adjuvant letrozole using a population pharmacokinetics approach in hormone receptor-positive breast cancer patients
5. Active immunologic participation and metabolic shutdown of kidney structural cells during kidney transplant rejection
6. Risk factors for mood disorders among offspring of parents with bipolar disorder: Findings from a discordant-sibling study
7. Semi-synthetic human albumin isoforms: Production, structure, binding capacities and influence on a routine laboratory test
8. A multi-omics investigation of tacrolimus off-target effects on a proximal tubule cell-line
9. Posttranslational-modifications of human-serum-albumin analysis by a top-down approach validated by a comprehensive bottom-up analysis
10. New perspectives for the therapeutic drug monitoring of tacrolimus: Quantification in volumetric DBS based on an automated extraction and LC-MS/MS analysis
11. Substrate binding and lipid-mediated allostery in the human organic anion transporter 1 at the atomic-scale
12. Machine learning-supported interpretation of kidney graft elementary lesions in combination with clinical data
13. Biological pathways and comparison with biopsy signals and cellular origin of peripheral blood transcriptomic profiles during kidney allograft pathology
14. How has the future investment program stimulated research and innovation in health?
15. Comment le programme d’investissements d’avenir a-t-il stimulé la recherche et l’innovation en santé ?
16. Real life experience of mycophenolate mofetil monotherapy in liver transplant patients
17. Development and validation of an optimized integrative model using urinary chemokines for noninvasive diagnosis of acute allograft rejection
18. Synthèse des recommandations de l’International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT) sur le suivi thérapeutique pharmacologique du tacrolimus
19. Urinary Protein Biomarker Panel for the Diagnosis of Antibody-Mediated Rejection in Kidney Transplant Recipients
20. Image-Based Marker-Free Screening of GABAA Agonists, Antagonists, and Modulators
21. Retinal function anomalies in young offspring at genetic risk of schizophrenia and mood disorder: The meaning for the illness pathophysiology
22. Automatic quantification of uracil and dihydrouracil in plasma
23. Health research and innovation: Can we optimize the interface between startups/pharmaceutical companies and academic health care institutions or not?
24. Recherche et innovation en santé : comment optimiser l’interface entre les startups/industries et les établissements de santé académiques ou non ?
25. What is the best source for searching drug with CIP codes in the French health reimbursement data system (SNDS) database?
26. Development and validation of a peripheral blood mRNA assay for the assessment of antibody-mediated kidney allograft rejection: A multicentre, prospective study
27. Natural killer cell infiltration is discriminative for antibody-mediated rejection and predicts outcome after kidney transplantation
28. Sample and substrate preparation for exploring living neurons in culture with quantitative-phase imaging
29. Ischemia/reperfusion-associated tubular cells injury in renal transplantation: Can metabolomics inform about mechanisms and help identify new therapeutic targets?
30. Comparative clinical trial of the variability factors of the exposure indices used for the drug monitoring of two tacrolimus formulations in kidney transplant recipients
31. Towards therapeutic drug monitoring of everolimus in cancer? Results of an exploratory study of exposure-effect relationship
32. Uterus tolerance to extended cold ischemic storage after auto-transplantation in ewes
33. Circulating oxysterol metabolites as potential new surrogate markers in patients with hormone receptor-positive breast cancer: Results of the OXYTAM study
34. Performance characteristics of the Access AMH assay for the quantitative determination of anti-Müllerian hormone (AMH) levels on the Access* family of automated immunoassay systems
35. Overview of accessibility and quality of antiepileptic drugs in Madagascar
36. In silico pharmacology: Drug membrane partitioning and crossing
37. Multidrug resistance-associated protein 4 (MRP4) controls ganciclovir intracellular accumulation and contributes to ganciclovir-induced neutropenia in renal transplant patients
38. Liability indicators aggregate many years before transition to illness in offspring descending from kindreds affected by schizophrenia or bipolar disorder
39. The specificity of the familial aggregation of early-onset bipolar disorder: A controlled 10-year follow-up study of offspring of parents with mood disorders
40. How to handle missed or delayed doses of tacrolimus in renal transplant recipients? A pharmacokinetic investigation
41. Mycophenolic mofetil optimized pharmacokinetic modelling, and exposure-effect associations in adult heart transplant recipients
42. Translational Research: Precision Medicine, Personalized Medicine, Targeted Therapies: Marketing or Science?
43. Recherche translationnelle : médecine personnalisée, médecine de précision, thérapies ciblées : marketing ou science ?
44. Uterus retrieval process from brain dead donors
45. Increased activation in Broca's area after cognitive remediation in schizophrenia
46. Untargeted screening of urinary peptides with liquid chromatography coupled to hybrid linear-ion trap tandem mass spectrometry
47. Simultaneous evaluation of six human glucuronidation activities in liver microsomes using liquid chromatography–tandem mass spectrometry
48. High b-value diffusion-weighted imaging: A sensitive method to reveal white matter differences in schizophrenia
49. SAT-052 Artificial intelligence and liver transplantation: posttransplantation chronic kidney disease prediction
50. How to Improve the Clinical Development Paradigm and its Division into Phases I, II and III
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.